JAC Advance Access published online on November 20, 2008
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkn484
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original research |
Carbapenem-hydrolysing β-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil
1 Oswaldo Cruz Institute, Avenida Brasil 4365, 21040-360 Rio de Janeiro, Brazil 2 Hospital Geral de Bonsucesso (HGB), Avenida Londres 616, 21041-030 Rio de Janeiro, Brazil 3 Hospital Universitário Antônio Pedro (HUAP)—Universidade Federal Fluminense, Rua Marquês de Paraná 303, 24033-900 Niterói, Brazil
Received 17 July 2008; returned 27 August 2008; revised 30 October 2008; accepted 31 October 2008
* Corresponding author. Tel: +55-21-2598-4277, ext. 319; Fax: +55-21-2270-6565; E-mail: peirano{at}ioc.fiocruz.br
Objectives: The aim of this study was to characterize the KPC-type carbapenem-hydrolysing β-lactamase, extended-spectrum β-lactamases (ESBLs) and class 1 integrons among nosocomial Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil.
Methods: MICs were determined and isolates were screened for ESBLs, metallo-β-lactamases (MBLs) and class A carbapenemase-producing phenotypes. The main β-lactamases resistance genes (blaTEM, blaSHV, blaCTX-M, blaKPC, blaIMP and blaVIM) and class 1 integrons were detected by PCR followed by DNA sequencing. The genetic relatedness of isolates was determined by PFGE.
Results: All K. pneumoniae isolates were positive for ESBL and class A carbapenemase production and negative for MBL production. All isolates were resistant to all β-lactam antibiotics, ciprofloxacin and gentamicin, being susceptible only to tigecycline and polymyxin B. The blaKPC-2, blaCTX-M-1, blaCTX-M-2, blaCTX-M-8 and blaSHV-11 genes were detected. PFGE analysis revealed two clonal types among KPC-producing isolates, both identified in the same hospital.
Conclusions: Our findings should alert medical authorities to implement stringent methods for the detection and spread control of emerging KPC-2 carbapenemases in the hospital setting in Brazil.
Key Words: multidrug resistance , class 1 integrons , PCR , PFGE
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Stachyra, P. Levasseur, M.-C. Pechereau, A.-M. Girard, M. Claudon, C. Miossec, and M. T. Black In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases J. Antimicrob. Chemother., August 1, 2009; 64(2): 326 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Endimiani, Y. Choudhary, and R. A. Bonomo In Vitro Activity of NXL104 in Combination with {beta}-Lactams against Klebsiella pneumoniae Isolates Producing KPC Carbapenemases Antimicrob. Agents Chemother., August 1, 2009; 53(8): 3599 - 3601. [Full Text] [PDF] |
||||
![]() |
M. Pavez, E. M. Mamizuka, and N. Lincopan Early Dissemination of KPC-2-Producing Klebsiella pneumoniae Strains in Brazil Antimicrob. Agents Chemother., June 1, 2009; 53(6): 2702 - 2702. [Full Text] [PDF] |
||||

